Vivian Y. Shi

High Impact

Role not yet determined Is this you? Add your title

UAMS primary UA Little Rock

Also affiliated: Boston University (2024); Northwestern University (2024); University of Southern California (2022); Centers for Disease Control and Prevention (2021); Apple (Israel) (2021); Harvard University (2023); University of Arizona (2016–2022); University of Illinois Urbana-Champaign (2011–2017); University of California, Los Angeles (2007–2022); Illinois College (2011–2017); University of California, San Francisco (2021); Providence College (2025); University of Washington (2024–2025); Loma Linda University (2015); University of Arkansas Medical Center (2020–2023); University of Alabama at Birmingham (2024); University of Illinois Chicago (2011–2017); Arkansas Cardiology (2020); Hasbro Children's Hospital (2025); Zero to Three (2022); Creative Commons (2021–2022); Banner - University Medical Center Tucson (2017–2020); Hospital of the Brothers of St. John of God (2009); Institute for Conflict Research (2021); Olive View-UCLA Medical Center (2020); Stanford Medicine (2023); Community Connections (2022); Vince Lombardi Cancer Clinic (2018); Eagle Mount (2021); Bayer (China) (2017); Jacobs Institute (2022); Jacobs (United States) (2022); University of California Davis Medical Center (2016); Arkansas Department of Agriculture (2020–2024); Tris Pharma (United States) (2021); Lebanese American University (2019); Seattle University (2024–2025); University at Buffalo, State University of New York (2022); Columbia University (2020–2021); University of California, Davis (2013–2016); Stanford University (2021–2024)

Formerly Arkansas Associate Professor, UAMS through 2024.

40 h-index 408 pubs 5,472 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group

OverviewAI-generated summary

Vivian Y. Shi's research focuses on dermatological conditions, particularly atopic dermatitis and hidradenitis suppurativa. Her work investigates the role of skin barrier function, sebaceous glands, and environmental factors in the pathogenesis of these inflammatory skin diseases. Shi has published on the mechanisms of skin barrier repair, including the potential benefits of natural oils, and has explored the link between epithelial barrier dysfunction and immune dysregulation in atopic dermatitis, suggesting a skin-gut-lung model. Her research also addresses the management of these conditions, as evidenced by her work on international guidelines for hidradenitis suppurativa and clinical trials for new treatments for atopic dermatitis.

Her scholarly output includes over 400 publications, with an h-index of 40 and over 5,400 citations, recognizing her as a highly cited researcher. Shi leads a research group at the University of Arkansas for Medical Sciences and collaborates with colleagues within the institution, including Charlotte Y. Jeong, Jay Kincannon, Edita M. Newton, and Henry Bishop. Her recent work has also touched upon the impact of COVID-19 on dermatological treatments and the effects of airborne pollution on skin conditions.

Metrics

h-index: 40
Publications: 408
Citations: 5,472

Positions

Associate Professor 2020–2024

University of Arkansas for Medical Sciences Department of Dermatology ORCID
Assistant Professor 2016–2020

University of Arizona Department of Dermatology ORCID

Selected Publications

Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry (2024)

Journal of Dermatological Treatment 6 citations DOI OpenAlex
Readability of Information Generated by ChatGPT for Hidradenitis Suppurativa (2024)

JMIR Dermatology 8 citations DOI OpenAlex
Ustekinumab in Hidradenitis Suppurativa: A Systematic Review and Meta-analysis (2024)

Dermatology and Therapy 9 citations DOI OpenAlex
Adherence to Hidradenitis Suppurativa Treatment (2024)

American Journal of Clinical Dermatology 6 citations DOI OpenAlex
Spironolactone in hidradenitis suppurativa: a single-center (2024)

International Journal of Women’s Dermatology 8 citations DOI OpenAlex
Expert Practices in Hidradenitis Suppurativa Flare Management: A Cross-Sectional Survey Study (2024)

Skin Appendage Disorders 11 citations DOI OpenAlex
Impact of Crisaborole in Treatment-Experienced Patients with Mild-to-Moderate Atopic Dermatitis (2024)

Dermatitis 6 citations DOI OpenAlex
No-Shows to Hidradenitis Suppurativa Clinic Visits: Patient Perspectives (2023)

Skin Health and Disease 6 citations DOI OpenAlex
Top cited articles in dissecting cellulitis of the scalp: A bibliometric analysis (2023)

Skin Research and Technology 6 citations DOI OpenAlex
Treatments for Dissecting Cellulitis of the Scalp: A Systematic Review and Treatment Algorithm (2023)

Dermatology and Therapy 29 citations DOI OpenAlex
The Skin Barrier and Moisturization: Function, Disruption, and Mechanisms of Repair (2023)

Skin Pharmacology and Physiology 177 citations DOI OpenAlex
Managing seasonal flares in hidradenitis suppurativa (2023)

Journal of the American Academy of Dermatology 6 citations DOI OpenAlex
Efficacy of medical treatments for pediatric hidradenitis suppurativa: A systematic review (2023)

Pediatric Dermatology 17 citations DOI OpenAlex
Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis Registry (2023)

Dermatology and Therapy 12 citations DOI OpenAlex
Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa—Part II: Procedural and Wound Care Therapies (2023)

Dermatology and Therapy 7 citations DOI OpenAlex